Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00002270 · ClinicalTrials.gov registry record · NA
A Pilot Study of the Efficacy of Recombinant Alpha Interferon (IFN-A2b) and Zidovudine (AZT) in the Treatment of Progressive Multifocal Leukoencephalopathy (PML) Complicating HIV-1 Infection
A NA study, sponsored by University of Miami.
- Completed
- Registry status
- NA
- Development phase
NCT00002270 is a NA study that has completed, run by University of Miami.
The verdict
NCT00002270, a NA study, has completed, sponsored by University of Miami.
- COMPLETED
- Registry status
- NA
- Development phase
Study Summary
To study the effectiveness of alpha interferon (IFN-A2b) and zidovudine (AZT) in treating progressive multifocal leukoencephalopathy (PML) as a complication of HIV-1 infection.
Interventions
- DRUG Zidovudine
- DRUG Interferon alfa-2b
Trial Details
| Field | Value |
|---|---|
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00002270
The ClinicalTrials.gov registry entry for NCT00002270 describes a study currently listed as completed, categorized as NA. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Zidovudine is the first listed.
NCT00002270 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00002270 about?
NCT00002270 is a clinical study titled "A Pilot Study of the Efficacy of Recombinant Alpha Interferon (IFN-A2b) and Zidovudine (AZT) in the Treatment of Progressive Multifocal Leukoencephalopathy (PML) Complicating HIV-1 Infection". To study the effectiveness of alpha interferon (IFN-A2b) and zidovudine (AZT) in treating progressive multifocal leukoencephalopathy (PML) as a complication of HIV-1 infection.
What is the current status of trial NCT00002270?
This trial is currently completed. It is a NA study.
What interventions are being tested in trial NCT00002270?
The interventions under investigation include: Zidovudine (DRUG), Interferon alfa-2b (DRUG).
Who is sponsoring clinical trial NCT00002270?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.